A Trial of AK117 (Anti-CD47) in Patients With Myelodysplastic Syndrome

Clinical trial NCT04900350 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04900350
Sponsor: Akeso
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2021-06-18
Primary completion: 2025-09-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.